While our beginnings are rooted in Internal Medicine, founding partners, Samuel Idarraga, MD FACP and Andrew Kim, MD FACP, exited system based medicine in 2003 to pursue more patient centric independent practices. We have been conducting clinical research since gaining independence in 2003 with 2009 representing a pivotal year in which we expanded our capabilities from merely two Principle Investigators in a few therapeutic areas to over thirty-two potential investigators in nine specialty areas. We have added capabilities in Allergy/Immunology, Cardiology, Dermatology, Ophthalmology, Neurology, Psychiatry, Radiology, and Wisconsin’s largest independent Gastroenterology group. These are examples of many such partnership alliances we have developed, harnessing the benefits of research participation as a vehicle to unify independent providers, keeping them on the cutting edge of knowledge and offering them a point competitive advantage that was once the safe harbor for institution alone.
Equally important to capability is our long history of more than thirteen years of research experience representing 90+ studies including landmark Crohn's, statin and male HPV studies. In 2010 we leveraged our experience, benchmark-able years of consistent enrollment and quality data gathering to earn the designation as a high Tier and Preferred Site from several pharmaceutical companies and CROs alike. This represents invaluable access to cutting edge opportunities, allowing us to plan for our future needs and even steer development through early interactions with development teams. It is exactly this access, coupled with capability, along with our history of successes which has garnered us the attention of leaders in the clinical research and pharmaceutical industries.
Tenemos socios que hablan Español!